VEGF in brain tumors is both tumor- and EC-derived and therefore exerts its effects in a paracrine and autocrine fashion through high affinity binding to the tyrosine kinase receptors VEGFR2/Flk-1 and VEGFR1/Flt-1 [94,95]. This evidence concerns the gene FLT1 and neoplasm.